Nongenetic mouse models of non-insulin-dependent diabetes mellitus - PubMed (original) (raw)
Nongenetic mouse models of non-insulin-dependent diabetes mellitus
J Luo et al. Metabolism. 1998 Jun.
Abstract
The purpose of the study was to develop a mouse model of non-insulin-dependent diabetes mellitus (NIDDM) that closely simulates the metabolic abnormalities of the human disease and is also cost-effective compared with the genetic models currently available. For this purpose, insulin resistance was induced in male C57BL/6J or Institute of Cancer Research (ICR) mice by feeding diets enriched in either fructose or fat, and hyperglycemia was induced by injecting these mice with a dose of streptozotocin (STZ) that does not cause diabetes in chow-fed mice. In the case of C57BL/6J mice, insulin levels initially increased in response to the fructose- and fat-enriched diets and then decreased to levels comparable to or still higher than those in chow-fed mice following STZ injection. Associated with the decrease in insulin levels following STZ, fat-fed and fructose-fed C57BL/6J mice became significantly hyperglycemic, reaching values of 388 +/- 38 and 366 +/- 58 mg/dL, respectively. In contrast, neither plasma glucose nor insulin concentrations changed in chow-fed mice injected with an identical amount of STZ. Essentially identical findings were seen before and after STZ injection in fat-fed compared with chow-fed ICR mice. Although a direct comparison was not made, sensitivity to the diabetogenic effects of STZ appeared to be greater in fat-fed ICR compared with fat-fed C57BL/6J mice. Finally, plasma glucose decreased when mice with these experimental models of NIDDM were treated with either metformin or tolbutamide. Given these results, it seems reasonable to suggest that the combination of dietary-induced insulin resistance and relatively low-dose STZ results in mouse models that should be of use in studying the pathophysiology of NIDDM or in evaluating therapeutic compounds for the treatment of NIDDM.
Similar articles
- A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat.
Reed MJ, Meszaros K, Entes LJ, Claypool MD, Pinkett JG, Gadbois TM, Reaven GM. Reed MJ, et al. Metabolism. 2000 Nov;49(11):1390-4. doi: 10.1053/meta.2000.17721. Metabolism. 2000. PMID: 11092499 - Investigation of insulin resistance in the popularly used four rat models of type-2 diabetes.
Chao PC, Li Y, Chang CH, Shieh JP, Cheng JT, Cheng KC. Chao PC, et al. Biomed Pharmacother. 2018 May;101:155-161. doi: 10.1016/j.biopha.2018.02.084. Epub 2018 Feb 24. Biomed Pharmacother. 2018. PMID: 29486333 - Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening.
Srinivasan K, Viswanad B, Asrat L, Kaul CL, Ramarao P. Srinivasan K, et al. Pharmacol Res. 2005 Oct;52(4):313-20. doi: 10.1016/j.phrs.2005.05.004. Pharmacol Res. 2005. PMID: 15979893 - Hyperinsulinemia and insulin resistance in hypertension: differential effects of antihypertensive agents.
Goyal RK. Goyal RK. Clin Exp Hypertens. 1999 Jan-Feb;21(1-2):167-79. doi: 10.3109/10641969909068659. Clin Exp Hypertens. 1999. PMID: 10052652 Review. - Mechanisms of insulin resistance and new pharmacological approaches to metabolism and diabetic complications.
Donnelly R, Qu X. Donnelly R, et al. Clin Exp Pharmacol Physiol. 1998 Feb;25(2):79-87. doi: 10.1111/j.1440-1681.1998.tb02181.x. Clin Exp Pharmacol Physiol. 1998. PMID: 9493493 Review.
Cited by
- A novel mice model of metabolic syndrome: the high-fat-high-fructose diet-fed ICR mice.
Zhuhua Z, Zhiquan W, Zhen Y, Yixin N, Weiwei Z, Xiaoyong L, Yueming L, Hongmei Z, Li Q, Qing S. Zhuhua Z, et al. Exp Anim. 2015;64(4):435-42. doi: 10.1538/expanim.14-0086. Epub 2015 Jul 2. Exp Anim. 2015. PMID: 26134356 Free PMC article. - Profile of the bile acid FXR-FGF15 pathway in the glucolipid metabolism disorder of diabetic mice suffering from chronic stress.
Cai W, Li C, Su Z, Cao J, Chen Z, Chen Y, Guo Z, Cai J, Xu F. Cai W, et al. PeerJ. 2023 Nov 15;11:e16407. doi: 10.7717/peerj.16407. eCollection 2023. PeerJ. 2023. PMID: 38025699 Free PMC article. - AICAR Improves Outcomes of Metabolic Syndrome and Type 2 Diabetes Induced by High-Fat Diet in C57Bl/6 Male Mice.
Tukhovskaya EA, Shaykhutdinova ER, Pakhomova IA, Slashcheva GA, Goryacheva NA, Sadovnikova ES, Rasskazova EA, Kazakov VA, Dyachenko IA, Frolova AA, Brovkin AN, Kaluzhsky VE, Beburov MY, Murashev AN. Tukhovskaya EA, et al. Int J Mol Sci. 2022 Dec 11;23(24):15719. doi: 10.3390/ijms232415719. Int J Mol Sci. 2022. PMID: 36555360 Free PMC article. - Sitagliptin: review of preclinical and clinical data regarding incidence of pancreatitis.
Engel SS, Williams-Herman DE, Golm GT, Clay RJ, Machotka SV, Kaufman KD, Goldstein BJ. Engel SS, et al. Int J Clin Pract. 2010 Jun;64(7):984-90. doi: 10.1111/j.1742-1241.2010.02382.x. Epub 2010 Apr 14. Int J Clin Pract. 2010. PMID: 20412332 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical